White label – Pompe disease - ClinicalTrials.eu

Study on Managing High Cholesterol in Cardiovascular Disease Patients Using Inclisiran

Not recruiting

3 1 1 1
Investigated Diseases:
- Primary hypercholesterolaemia
Investigated Drugs:
- Inclisiran
Study on the Safety of Avelumab for Patients with Solid Tumors Continuing Treatment

Not recruiting

3 1 1 1
Investigated Diseases:
- Neoplasm
Investigated Drugs:
- Avelumab
+1
Study on Talazoparib and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

Not recruiting

3 1 1
Investigated Drugs:
- Talazoparib
- Enzalutamide
+6
Study Comparing Anakinra and Prednisone for Treating Gout Flare in Patients with Advanced Kidney Disease or Kidney Transplant

Not recruiting

3 1 1
Investigated Diseases:
- Renal failure
Investigated Drugs:
- Anakinra
- Prednisone
Study of Cobolimab and Dostarlimab for Children and Young Adults with Newly Diagnosed or Relapsed/Refractory Tumors

Not recruiting

1 1 1 1
Investigated Diseases:
Investigated Drugs:
- Cobolimab
- Dostarlimab
Study on the Effectiveness and Safety of Frexalimab and Teriflunomide in Adults with Relapsing Multiple Sclerosis

Not recruiting

3 1 1
Investigated Drugs:
+10
Study on Tulisokibart for Treating Moderate to Severe Crohn’s Disease in Adults

Not recruiting

3 1
Investigated Diseases:
- Crohn’s disease
Investigated Drugs:
- Tulisokibart
+15
Study of Retifanlimab, INCAGN02385, and INCAGN02390 for First-Line Treatment in Patients with PD-L1 Positive Recurrent/Metastatic Head and Neck Cancer

Not recruiting

2 1 1
Investigated Diseases:
- Squamous cell carcinoma of head and neck
Investigated Drugs:
Study on the Effects of Cenerimod for Adults with Moderate to Severe Systemic Lupus Erythematosus

Not recruiting

3 1
Investigated Diseases:
- Systemic lupus erythematosus
Investigated Drugs:
- Cenerimod
Study of Imlifidase for Patients Undergoing Kidney Transplant from a Living Donor

Not recruiting

2 1 1 1
Investigated Diseases:
- Renal transplant
Investigated Drugs:
- Imlifidase

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies